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Abstract
Background: Gait disorders of Parkinson’s disease (PD) are characterized by the breakdown of the temporal
organization of stride duration variability that was tightly associated to dynamic instability in PD. Activating the
upper body during walking, Nordic Walking (NW) may be used as an external cueing to improve spatiotemporal
parameters of gait, such as stride length or gait variability, in PD. The aim of this study was to evaluate the
beneficial effects of NW on temporal organization of gait variability and spatiotemporal gait variables in PD.
Methods: Fourteen mild to moderate PD participants and ten age-matched healthy subjects performed 2 × 12 min
overground walking sessions (with and without pole in a randomized order) at a comfortable speed. Gait speed,
cadence, step length and temporal organization (i.e. long-range autocorrelations; LRA) of stride duration variability
were studied on 512 consecutive gait cycles using a unidimensional accelerometer placed on the malleola of the
most affected side in PD patients and of the dominant side in healthy controls. The presence of LRA was
determined using the Rescaled Range Analysis (Hurst exponent) and the Power Spectral Density (α exponent). To
assess NW and disease influences on gait, paired t-tests, Z-score and a two-way (pathological condition x walking
condition) ANOVA repeated measure were used.
Results: Leading to significant improvement of LRA, NW enhances step length and reduces gait cadence without
any change in gait speed in PD. Interestingly, LRA and step length collected from the NW session are similar to that
of the healthy population.
Conclusion: This cross-sectional controlled study demonstrates that NW may constitute a powerful way to struggle
against the randomness of PD gait and the typical gait hypokinesia. Involving a voluntary intersegmental
coordination, such improvement could also be due to the upper body rhythmic movements acting as rhythmical
external cue to bypass their defective basal ganglia circuitries.
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Background
Scaling and timing internal control required for automatic
and rhythmical movements are impaired and archetypally
linked to the basal ganglia dysfunction in Parkinson’s
disease (PD). As a result of such impairment, a reduced
gait speed, shorter stride length, reduced arm swing and a
random walking pattern (i.e. increased gait variability) are
typical features of PD gait [1–5]. From the specific
temporal point of view, the inability to produce a steady
gait rhythm, which result in more random stride-to-stride
variability, is one of the primary temporal gait disorders
and can indicate a sensitive marker of a higher fall risk in
PD [5, 6].
Interestingly, the randomness of PD gait was recently
emphasized by subtle deterioration of the temporal
organization of gait variability, using the long-range
autocorrelations (LRA) assessment [6]. In addition, close
correlations with disease severity and balance status
were demonstrated in PD [6]. In a more theoretical
framework, LRA have indeed been suggested as an indi-
cator of adaptive abilities characterizing healthy systems
[5, 7–9]. As a corollary, deviations from an optimal level
of variability in either the direction of randomness or
the over-regularity are thought to reflect the loss of the
adaptive capabilities of the system [8].
Consequently, interventions that improve LRA might
be beneficial in PD gait, which is characterized by less
efficient adaptive resources. Among numerous rehabili-
tative approaches, Nordic Walking (NW) holds a special
place in PD as an emerging and promising strategy to
stimulate an active lifestyle [10]. Using specially designed
poles, NW involves an intentional coordination between
upper and lower limbs and could constitute an interesting
option to enhance the stride length and the gait speed
[11–13]. Furthermore, the use of Nordic poles may act as
an external cue, triggering intact circuits and bypassing
the defective basal ganglia—SMA loop. This permits
compensating for the impaired scaling and timing control
in PD [12].
However, it remains unknown whether Nordic Walking,
without any long-term training, can influence real-time
spatial and temporal gait variables in Parkinson’s disease,
and especially long-range autocorrelations. Therefore, this
study is aimed primarily at assessing LRA, as well as
spatiotemporal gait variables, by means of comparison
between NW and Usual Walking (UW) in PD. Con-
sidering NW may act as an external cue to restore
control movement [12], our primary hypothesis is that
gait variability would become less random and spatio-
temporal gait variables would improve with such a re-
habilitative approach. Secondarily, the study is aimed
at comparing long-range autocorrelations and gait
variables in the PD population to healthy adults while
usual and Nordic walking.
Methods
Participants
Fourteen PD participants were enrolled from the
Neurology Department of the Cliniques universitaires
Saint-Luc, Brussels (AJ) and from the “Association
Parkinson”, Namur (Table 1). Note that several partic-
ipants were directly recruited from another previous
study which presented the same eligibility criteria [6].
This previous study aimed to investigate the potential
usefulness of LRA assessment as a marker of gait
instability in PD. A minimum of 6 months has been
respected between the two studies. Eligibility criteria
included: (1) fulfilment of the United Kingdom
Parkinson's Disease Society Brain Bank (UKBB) cri-
teria for idiopathic PD [14] and (2) ability to perform
512 consecutive strides without the need for walking aids.
Such series length is required to adequately apply math-
ematical methods described below [15]. Exclusion criteria
comprised of history of other neurologic disorders or
orthopaedic pathologies known to impair gait perform-
ance. Ten age-matched healthy control participants
(Table 1) were recruited as a control group.
Ethics, consent and permissions
Testing took place at the Cliniques universitaires
Saint-Luc, Brussels from September 2015 till November
2016. This study was conducted according to the declar-
ation of Helsinki and had ethical approval from the
Comité d’Ethique Hospitalo-Facultaire de l’Université
Table 1 Characteristics of the study populations
PD (n = 14) Healthy
(n = 10)
p-value
Age (years) 62.2±6.9 60.3±4.8 0.525
Gender (male/female) 9/5 3/7
Height (cm) 171.8±10.3 170.3±7.6 0.813
Weight (kg) 74.7±15.9 67.8±10.7 0.186
Time since the diagnosis (years) 4.5±2.7 -
MMSE score (/30) 29.5 [27–30] 30 [29–30] 0.049
H&Y scale 2 [1–3] -
1 (n=): 2 -
1,5 (n=): 2 -
2 (n=): 5 -
2,5 (n=): 3 -
3 (n=): 2 -
MDS-UPDRS III (/132) 26.9 [10–46] -
MDS-UPDRS total (/260) 52.3 [18–94] -
BESTest total (%) 77.4 [69–92] 87.7 [85.2–96] ≤0.001
ABC Scale (%) 79.0 [54–100] 95.0 [72–100] 0.014
Mean (±SD) are expressed for quantitative variables normally distributed while
median [range] are expressed for both ordinal and non-normally distributed
variables
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catholique de Louvain (B403201318916/Clinical Trial
registration: NCT02419768). Participants gave written
informed consent prior to data collection.
Procedure
During UW and NW sessions, a unidimensional acceler-
ometer was taped, in the antero-posterior direction, on
to the lateral malleolus of the side most affected by
motor symptoms of PD and of the dominant side for
healthy participants. Acceleration data was recorded at
512 Hz using the Vitaport three ambulatory recorder
(Temec Instruments B.V., Kerkrade, The Netherlands),
and transferred to a computer. The stride duration was
determined from the peak of acceleration (i.e. peak de-
tection method [16–20]; Fig. 1) detected by the software
internally developed and confirmed visually. The visual
inspection consisted of checking each acceleration peak
detected after the application of the peak detection
algorithm to ensure a precise measure of successive
stride durations and subsequently its variability. Validated
against ground reaction forces, the peak detection method
assumes that each acceleration peak corresponds to suc-
cessive foot contact [16, 18]. The peak detection method
was designed to minimize the risk of false step detection
making it the most accurate compared with other
techniques (e.g. zero-crossing method) [16, 17]. Accel-
erometer data was collected during a walking session
of 12 min that consisted of walking overground at a
self-selected speed around a 42 m oval indoor track
with and without Nordic poles (usual and Nordic
walking sessions). The two walking sessions were per-
formed in a quiet environment to avoid all external
perturbations that could increase the attentional cost
of walking. Concerning NW, each PD and healthy
participant received three 1-h sessions to learn the
walking technique (ALFA method). Note that all PD
and healthy participants were naive with NW tech-
nique prior to the study. The training sessions were
delivered 1 week before the experimental sessions.
The number of training sessions was limited to three to
allow enough time to learn the basic walking technique
but not to induce motor learning [10]. Experimental ses-
sions were spread over two consecutive days and at the
same part of the day in order to, respectively, reduce the
fatigue and medication influences on gait in PD partici-
pants [21, 22]. Also, the order of the two walking sessions
was randomly allocated in order to avoid any gait rehabili-
tation benefits. Before the NW session, the walking
technique of each patient was verified (MBL). Although
the technique learning and familiarization period was
respected, no specific instructions on gait pattern were
delivered.
Each participant underwent a comprehensive assess-
ment when medication provided significant functional
improvement (ON phase), 60–120 min after their last
medication intake. The severity of PD (modified H&Y
scale), the patient’s functional status (Movement
Disorder Society—Unified Parkinson’s Disease Rating
Scale (MDS-UPDRS)), and the subjects’ performance on
a balance test (BESTest) were assessed and the Activities
Balance Confidence questionnaire (Activities-specific
Balance Confidence Scale (ABC Scale)) was administered.
Gait assessment
Stride duration variability
Stride duration variability can be investigated either in
terms of magnitude, using standard metrics such as
sample mean, standard deviation (SD) and coefficient of
variation (CV), or in terms of its organization (i.e. LRA),
which provides complementary information on how
stride duration evolves with time across consecutive
strides [23, 24].
Temporal organization of the stride duration
variability (LRA) The presence of LRA was evaluated,
using an integrated approach that combines the results
of Rescaled Range Analysis (Hurst exponent; H) and
Power Spectral Density (α exponent). For each time
series, both methods were applied to sequences of 512
consecutive gait strides [16]. To increase the level of
confidence in the results, the consistency of H and α expo-
nents was verified using the asymptotic relationship d =H
- [(1 + α)/2] [15]. Following this integrated approach, the
Fig. 1 Stride duration determination—Peak detection method. Heel
strikes correspond to each positive acceleration peak (*; peak detection
method). The time between successive heel contacts corresponds to
the stride duration
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following three criteria must be met to conclude the pres-
ence of LRA:
 H > 0.5
 α significantly different from 0 and lower than 1
 d ≤ 0.10
For further details, these methods are described
elsewhere [15].
Magnitude of the stride duration variability (CV)
Recently suggested as reflecting the attentional load
allocated to the motor task [25], the magnitude of stride
duration variability was assessed using the coefficient of
variation (CV = [SD/mean] * 100) which was calculated
for the 512 consecutive stride previously selected for
each time series.
Spatiotemporal gait variables
Lap times and the number of laps were measured. The
total distance was determined from the number of laps
of 42 m performed by the participants. Following the re-
lationship between total walking distance and acquisition
duration, mean gait speed, mean gait cadence and mean
step length was independently assessed as follow:
Mean gait speed (m.s-1) = Total walking distance (m)/
Acquisition duration (s)
Gait cadence (#steps.min-1) = Total number of steps
(#)/Acquisition duration
(min)
Step length (m) = Gait speed/Gait cadence
Note that stride duration variability and spatiotemporal
gait variables were extracted from 512 consecutive gait
strides. This large data number is required to measure gait
variability, in particular to draw adequate conclusions
about the temporal organization of the stride duration
variability [15].
Transformation of gait data into Z-score
As age and walking speed were shown to influence gait
variables [26, 27], individual participant values were nor-
malized to Z-score to identify PD-caused gait alterations
as opposed to changes arising solely from the age of
subjects or from different walking speeds. Normative
data of spatiotemporal gait variables were extracted
from the Andriacchi et al. and Winter’s reference
works [26, 27]. Given that no normative values for H
and α exponents are currently established and that no
influence of age and gait speed were demonstrated,
values from our healthy control population were used
as a reference point. Whereas the influence of gait
speed on the CV of stride duration was highlighted at
low speeds (i.e. 0.2 to 0.6 m.s-1), people with PD with
mild and moderate motor symptoms usually walk at a
gait speed above 1 m.s-1 [6, 23, 25, 28–30]. Thus,
considering this aspect and the absence of normative
data for the CV of stride duration, healthy control
values were also used as a reference point.
Statistical analysis
Sample size calculation was performed for the Hurst
exponent as the main outcome. A sample size of 14
participants (power = 0.8, alpha = 0.05) was required to
detect similar differences as the study of Hove et al. that
investigated the influence of the rhythmic auditory
stimulation on the temporal organization of the stride
duration variability in PD [31].
Anthropometric and clinical characteristics were ana-
lysed with independent samples t-tests. A paired t-test
and a two-way ANOVA (Walking condition x Patho-
logical condition) repeated measure were applied to
examine the influence of walking condition, as well as
one of the pathological condition on LRA exponents,
CV of stride duration and spatiotemporal gait variables.
Holm-Sidak post hoc tests were performed and the
effect size (partial eta squared; η2p) was measured.
One-sample t-test or Wilcoxon signed-rank test (non-
normally distributed variables) against zero was used to
compare subjects Z-transformed gait variables with nor-
mal values (corresponding to Z score = 0). The results
were considered statistically different for p-values < 0.05.
Results
Anthropometric and clinical characteristics of the fourteen
PD participants and the ten healthy controls are summa-
rized in Table 1. PD participants presented mild to moder-
ate motor symptoms, corresponding to stage one to three
on the modified Hoehn & Yahr scale. Two patients
suffered from motor fluctuations. However, none of them
presented such fluctuations during the two walking
sessions. The two groups were matched for age and height.
PD participants reached significantly lower scores in
balance performance and confidence compared to healthy
controls.
Stride duration variability
The temporal organization and the magnitude of the
stride duration variability are presented in Figs. 2, 3 and
4 and in Table 2.
Temporal organization of the stride duration
variability (LRA) The integrated approach showed the
presence of LRA in both UW and NW in all the subjects
(Fig. 2 and Table 2). All values of the H exponent were
greater than 0.5, the α exponent was always significantly
different to 0, and all values of d were far below 0.10
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(0.02 ± 0.03 and 0.02 ± 0.03 for UW and NW,
respectively).
However, in PD participants, highly statistically signifi-
cant differences were observed between the two walking
conditions (p ≤ 0.001 and p = 0.003 for H and α expo-
nents, respectively; Fig. 2), H and α exponents being
lower in UW compared to NW (i.e. closer to 0.5 and 0
for H and α exponents, respectively). Conversely, the
walking conditions had no effect on H and α exponents
among healthy controls. Importantly, a significant
(Walking condition x Pathological condition) inter-
action (F = 7.421; p = 0.012 for H exponent, and F =
11.643; p = 0.002 for α exponent) was demonstrated,
as illustrated in Fig. 3 and reported in Table 2. Post-
hoc comparisons confirmed that the use of Nordic
poles influenced exclusively the PD participants’ gait
(Fig. 3). LRA exponents values collected from UW
were significantly lower than that of healthy adults
(p ≤ 0.001 for both exponents; Figs. 2 and 3 and
Table 3), while they did not differ during the NW
session, which suggest an improvement in the tem-
poral organization of the gait pattern with the use of
Nordic poles compared to the more randomness
variability observed in UW.
Magnitude of the stride duration variability (CV)
Regarding the stride duration fluctuation magnitude, the
values of CV were statistically higher during NW than
during UW for both populations (p = 0.002 and p =
0.045 for PD and healthy participants, respectively)
(Fig. 4 and Table 2). Importantly, no significant (Walking
condition x Pathological condition) interaction was
observed (F = 1.366; p = 0.255), confirming that the use
of Nordic poles influenced similarly the CV of both PD
and healthy participants. In comparison to the healthy
population, CV is higher with the use of Nordic poles
(p ≤ 0.001) while CV was similar to the healthy popula-
tion without Nordic poles (Table 3), which can suggest a
more attention-challenging task for PD participants.
Spatiotemporal gait variables
Mean absolute and Z-score values for gait speed,
cadence and step length are summarized in Fig. 5 and
Tables 2 and 3.
While the gait speed remained similar between the
two walking conditions (p = 0.146), the use of Nordic
poles significantly improved the step length (p ≤ 0.001)
and significantly reduced the gait cadence (p ≤ 0.001) in
comparison to the UW session (Table 2 and Fig. 5). No
significant (Walking condition x Pathological condition)
interaction was observed (F = 0.547; p = 0.468, F = 3.854;
p = 0.063, F = 0.839; p = 0.370 for gait speed, cadence and
step length, respectively), suggesting a similar influence
of NW on spatiotemporal gait variables for both PD and
healthy participants. Compared to the healthy popula-
tion, PD participants demonstrated a statistically signifi-
cant reduction in gait speed (p ≤ 0.001) during UW as
well as a reduced step length (p ≤ 0.001), while gait
Fig. 2 Temporal organization of stride duration variability. Comparison of Hurst and α exponents on usual walking (UW; ○) and Nordic walking
(NW; ) in PD and comparison with healthy adults (Z-score)
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cadence remained similar to healthy adults. During NW,
the gait speed was slightly reduced (p = 0.049) as well as
the gait cadence (p ≤ 0.001) whereas the step length was
significantly improved.
Discussion
In this study, we aimed to gain more insight into the
immediate effect of Nordic walking on the temporal
organization of gait variability (i.e. LRA) as well as on
spatiotemporal gait variables in PD participants. Actively
involving rhythmic movements of the upper body, Nordic
walking (NW) leads to significant improvement of LRA
compared to the more random gait pattern highlighted
during the usual walking session (UW). Additionally, NW
enhances step length without any change in gait speed.
Interestingly, LRA and step length collected from the NW
session are similar to that of the healthy population. Those
findings strongly support resorting to the use of Nordic
poles in the struggle against the randomness of PD gait
and the typical gait hypokinesia.
The randomness of PD gait pattern on UW contrasts
with the structured gait pattern of age-matched healthy
adults. Indeed, stride duration variability on UW appears
less structured in PD (i.e. lower LRA exponent values).
LRA, highlighted in gait and other rhythmic physio-
logical signals, are thought of as the signature of subtle
and complex interactions between subcomponents con-
stituting dynamical systems [9, 32]. Locomotor systems
ranks among those systems that need to continuously
adapt their pattern to constraints imposed by daily living
activities [8]. The randomness of PD gait pattern could
thus result from the defective activity among interacting
subcomponents (e.g. basal ganglia). Furthermore, the
breakdown of LRA highlighted in the specific context of
basal ganglia disorders (e.g. Parkinson’s and Hunting-
ton’s diseases) was strongly associated with balance and
functional status, and was suggested as a quantitative
clinical measure of dynamic instability [6, 33].
Fig. 3 Influence of pathological and walking conditions on Hurst
and α exponents in PD and healthy participants. Post-hoc analysis
for the (Pathological x Walking) interaction for LRA exponents in
PD (white and grey circles for usual and Nordic walking sessions,
respectively; black solid line) and healthy controls (white and grey
squares for usual and Nordic walking sessions, respectively; black
dashed line)
Fig. 4 Magnitude of stride duration variability. Comparison of coefficient of variation of stride duration variability (CV) on usual walking (UW; ○)
and Nordic walking (NW; ) in PD and comparison with healthy adults (Z-score)
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Compensating or restoring interactions among mul-
tiple components involved in healthy gait pattern is a
key factor in restoring adaptability and flexibility of loco-
motion. Interestingly, NW can modulate some temporal
organization in PD gait pattern (Fig. 3). LRA exponents
were indeed significantly higher with Nordic poles than
with usual walking in PD participants and similar to that
of the healthy population, characterized by functional
and adaptive locomotion (Tables 2 and 3 and Figs. 2
and 3). The use of Nordic poles allows a more temporally
organized behaviour than with UW, which suggest a more
effective and powerful coordination of sub-components
constituting the locomotor system [8, 9, 32].
Note that the α exponent seemed to decrease between
the two walking conditions in healthy adults (Table 2).
However, the exponent value remained at a “healthy”
level (Mean α exponent ± SD: 0.56 ± 0.17) [34]. In
addition, such eventual decrease of LRA should be con-
sidered within the integrated approach applied in our
study. While the effect size is small (Cohen’s d = 0.21)
and non-statistically significant (p = 0.453) for the α
exponent in healthy population, no effect size was
demonstrated for the Hurst exponent (Cohen’s d = 0.12;
p = 0.562). On the other hand, the increase of α exponent
is large and highly significant (Cohen’s d = 1.07; p < 0.001)
in PD participants and evolves in the same way that H
Table 2 Absolute mean values of the stride duration variability and spatiotemporal gait variables for the comparison between the
usual walking (UW) and the Nordic walking (NW) sessions in Parkinson’s disease and healthy controls and analysis of the
(Pathological x Walking conditions) interaction for the stride duration variability and spatiotemporal gait variables
Parkinson’s disease Healthy controls Interaction
UW NW UW NW p-value η2p
Stride duration variability
Temporal organization
H exponent 0.70 (±0.05) 0.77 (±0.08)*** 0.80 (±0.09)§§ 0.81 (±0.08) 0.012 0.252
α exponent 0.39 (±0.12) 0.56 (±0.19)** 0.56 (±0.22)§ 0.52 (±0.14) 0.002 0.346
Magnitude
CV (%) 2.26 (±0.66) 3.59 (±1.11)** 2.17 (±0.82) 2.92 (±0.91)* 0.255 0.058
Spatiotemporal gait variables
Gait speed (m/s) 1.18 (±0.19) 1.26 (±0.24) 1.47 (±0.17) 1.59 (±0.14)** 0.468 0.025
Gait cadence (#steps/min) 112.90 (±9.48) 102.83 (±13.16)** 119.22 (±4.55) 117.15 (±5.47)* 0.063 0.155
Step length (m) 0.63 (±0.09) 0.73 (±0.09)*** 0.74 (±0.09) 0.81 (±0.08)** 0.370 0.038
Absolute value is expressed as mean (± SD)
***: p ≤ 0.001; **p ≤ 0.01; *p ≤ 0.05 for the comparison between UW and NW (paired t-test)
§§§: p ≤ 0.001; §§ p ≤ 0.01; § p ≤ 0.05 for the comparison of walking conditions between PD and healthy controls (independent t-test)
Bold data indicates if (pathological x walking condition) interaction was significant (p < 0.05)
η2p: partial eta squared
Table 3 Mean values of the normalized stride duration variability and spatiotemporal gait variables (Z-score) for the comparison
between the usual walking (UW) and the Nordic walking (NW) sessions in Parkinson’s disease
Z-score
UW p-value NW p-value
Stride duration variability
Temporal organization
H exponent −1.14 (±0.60) ≤0.001 −0.31 (±0.97) 0.254
α exponent −0.70 (±0.51) ≤0.001 0.49 [−0.59; 0.56] 0.715
Magnitude
CV (%) 0.11 (±0.81) 0.632 1.72 (±1.35) ≤0.001
Spatiotemporal gait variables
Gait speed (m/s) −1.51 (±1.33) ≤0.001 −0.97 (±1.67) 0.049
Gait cadence (#steps/min) −0.94 (±1.71) 0.059 −2.99 [−3.51; −0.13] ≤0.001
Step length (m) −0.65 (±0.38) ≤0.001 0.09 (±0.43) 0.406
Z-score is expressed as mean (± SD) (one-sample t-test) or median [range] (one-sample Wilcoxon signed-rank test)
Bold data indicates if the Z-score significantly differed from 0 (p < 0.05): One-sample t-test (normally distributed values) or one-sample Wilcoxon signed-rank test
(non-normally distributed values)
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exponent (Cohen’s d = 1.05; p < 0.001). Therefore, the use
of Nordic poles is beneficial for the PD walking pattern
whereas it does not affect the walking pattern of healthy
population.
Modulation of spatio-temporal gait parameters also
seems different for people with PD walking with and
without the Nordic poles (Tables 2 and 3 and Fig. 5).
Although the gait speed in UW and in NW remained
slower than in healthy adults, the overall modulation of
spatio-temporal gait parameters with the Nordic poles
was similar to healthy adults. While the reduced gait
speed during UW was largely attributed to hypokinesia
(significant reduction of step length), the gait speed in
NW is modulated by both a significant improvement in
step length and a reduction in gait cadence, which is
particularly interesting in PD gait disorders manage-
ment. Although the reduction of gait cadence could be
perceived as dramatic, it should be noted that such de-
crease is usually observed with attentional strategies that
specifically focus on step length criterion [28, 35].
Decreased gait speed in PD is indeed largely attributed
to difficulties in generating appropriate stride length
while cadence control, used as a compensatory mechan-
ism, remains intact [1–4]. However, Morris et al. demon-
strated that the ability to generate a normal stepping
pattern is not lost in PD [2]. Normal movement ampli-
tude could be indeed elicited in PD given the appropri-
ate conditions such as the use of attentional resources or
external cues [2, 28]. Both strategies appear to share the
same mechanism of focusing attention on the stride
length criterion [2].
Attention involvement in gait control on NW could be
highlighted by a higher magnitude of gait variability (i.e.
CV of stride duration variability; Fig. 4), as recently
suggested by Ayoubi et al. in their meta-analysis [25].
Attentional strategies are indeed often used to compen-
sate for the impaired automaticity and could be involved
in NW [2, 36]. People with PD need to continuously
think about their movement, sequencing the whole
movement into sub-movement and the use of the frontal
cortex facilitates movement size and timing regulation
[36]. During NW, both PD and healthy participants were
implicitly focused on walking and their attention was
directed to the desired movement patterns [12]. The
higher magnitude of the stride duration variability
observed in all participants could be the signature of the
attention involved in the task being performed, which
could be observed with novice participants [37]. In
addition, walking with Nordic poles involves the
intentional action to move upper limbs in a coordinated
Fig. 5 Spatiotemporal gait parameters. Comparison of gait variables on usual walking (UW;○) and Nordic walking (NW; ) in PD and comparison
with healthy adults (Z-score)
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fashion with legs, improving the movement of the most
affected side in PD.
Therefore, NW appears to be an interesting rehabilita-
tive option as arm swing is reduced in PD [38]. Recent
studies agree wholeheartedly with the usefulness of arm
swing on the stability of gait, especially in the elderly
[38, 39]. Moreover, gait seems to be more stable when
the arm swing is amplified and could normalize the gait
speed and the step length in this population [38]. As
already highlighted by Punt et al., this finding is important
as the fall risk is already high for the elderly, and even
more so in PD [39, 40]. From this point of view, including
arm swing in rehabilitation programmes, it seems to
be an interesting strategy to normalize the PD gait
pattern [38, 41]. In particular, it has been suggested
that normalizing coordination between limbs could
improve gait in people with PD [38].
Arm swing is integrated into locomotion via tight
neuronal interlimb coordination using specialized neural
circuits in the spinal cord (central pattern generators,
CPGs) [42]. Although such neuronal networks are able
to produce coordinated motor patterns independently,
the CPG output can be modulated by afferent feedback
(i.e. cutaneous, joint and muscle input) and/or suprasp-
inal input (i.e. cortical control) [41–45]. Interestingly, it
has been demonstrated that cutaneous stimulation of
the hand evoked significant changes in lower limb kine-
matics in healthy adults, with an increase in dorsiflexion
at the stance-swing transition [46].
In addition, to help focus attention on walking, the use
of Nordic poles could also act as an external sensory cue
providing the necessary trigger in PD to bypass the
defective pallidocortical circuit [12]. Among multiple
cueing modalities, auditory and visual cues are the most
studied [47, 48]. However, tactile and proprioceptive cues
have also demonstrated their usefulness in the struggle
against the impaired gait automaticity, despite suggestions
of impaired somatosensory function in PD [3].
From a biomechanical point of view, the use of Nordic
poles implies a mechanically different movement pattern
than UW [49–51]. By increasing the base of support, the
use of poles helps to preserve gait stability after an
unpredictable perturbation [52]. Nordic poles could
serve as walking aids that are commonly prescribed to
maintain balance in people with PD. However, the pro-
pulsive use of poles could reduce any alteration of the
gait pattern classically observed with usual walking aids
[49, 53, 54]. Also, higher impulse values and higher knee
and ankle moments in the sagittal plane compared to
UW could indicate a more dynamic movement in
NW [50, 51].
Although the use of Nordic poles seems to be effective
in PD, our results should be carefully extended to the
whole disease severity spectrum. As recently highlighted,
people with PD with only slight and mild gait impair-
ment benefit most from NW [55]. The coordination
between limbs during gait seems to be compromised of
both bradykinesia and rigidity, which increase with the
pathological progression, while the adaptive abilities of
arm-leg coordination is preserved in people with PD in
the early stage of the disease [56]. Also, people with PD
often resort to cognitive strategies to compensate for a
lack of gait automacity [57]. However, such compensa-
tory strategies are useful as long as the cognitive
resources are preserved [11, 57]. The attentional involve-
ment on gait induced by the use of Nordic poles could,
as a result, be thus compromised in people with PD in
the latest stages of the disease.
Some limitations of this study should be addressed.
Motor complications, such as freezing of gait or dyskinesia,
could alter the gait dynamics. However, only two patients
suffered from such complications (one from freezing of gait
and one from dyskinesia of the upper limb) and none of
them presented such complications during the walking
trial. Also, note that participants were probably the most
motivated since they already participated in a previous
study. Thus, our results should be interpreted in light
of this specific aspect. To better characterize the gait
rhythmicity, ankle accelerometry was preferred to other
locations since a significant degree of attenuation of the
heel strike transient occurs during the passage to the
head [58]. Acceleration peaks are indeed higher and
straighter in ankles than the trunk, or even more the
head, which could improve the peak detection method
by minimizing false-acceleration peak detection. Hence,
the results concern the temporal organization of stride
duration variability measured from accelerations of the
ankles and comparisons with other studies should take
into account that other studies extract gait variability
from different devices (foot switches [5, 22], inertial
sensors [59], accelerometer [34], force platforms [60],
optoelectric system [61]) and other body parts (trunk
[17], knee [61], ankle [34]) to assess LRA.
While several clinical trials were recently conducted to
study the influence of NW on both motor and non-
motor symptoms in PD [10–12], none assessed the
beneficial effects of NW program on LRA, as a gait
stability index. This study can constitute a pilot study
offering new perspective to better characterize the sensi-
tivity of the temporal organization of gait variability to
rehabilitation approaches. Thus, it would be interesting
to investigate the effectiveness of a tailored NW program
on gait stability, concurrently assessed with clinical bal-
ance measures in a randomized control clinical trial.
Conclusion
In addition to the improvement of the typical gait hypo-
kinesia, this study demonstrates in PD that the temporal
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organization of gait variability, which is considered as a
marker of healthy locomotion, could be modulated while
using the Nordic poles. Involving a voluntary interseg-
mental coordination, such improvement could also be
due to the upper body rhythmic movements acting as a
rhythmic external cue to bypass the defective basal gan-
glia circuitries of PD. Therefore, Nordic walking may
constitute a powerful way to manage gait disorders in
PD, while being an accessible and affordable physical
activity which offers the advantage that the activity can
be performed by everybody, everywhere and at almost
any time.
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